Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04630847 · ClinicalTrials.gov registry record · Phase 1
Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders
A Phase 1 study, sponsored by ProgenaBiome.
- Not yet
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT04630847 is a Phase 1 study that has not yet begun recruiting, run by ProgenaBiome. The registered enrollment target is 10 participants.
The verdict
NCT04630847, a Phase 1 study, has not yet begun recruiting, sponsored by ProgenaBiome.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is an open-label clinical trial to evaluate the benefits of familial fecal microbiota transplant following a 6-week treatment with Vancomycin in adult subjects with ASD for treatment of social deficits and language delays.
Interventions
- BIOLOGICAL Fecal Microbiota Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-12 |
| Est. Completion | 2027-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04630847
The ClinicalTrials.gov registry entry for NCT04630847 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ProgenaBiome, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fecal Microbiota Transplant is the first listed.
NCT04630847 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04630847 about?
NCT04630847 is a clinical study titled "Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders". This is an open-label clinical trial to evaluate the benefits of familial fecal microbiota transplant following a 6-week treatment with Vancomycin in adult subjects with ASD for treatment of social deficits and language delays.
What is the current status of trial NCT04630847?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2025-12. Estimated completion is 2027-07.
What interventions are being tested in trial NCT04630847?
The interventions under investigation include: Fecal Microbiota Transplant (BIOLOGICAL).
Who is sponsoring clinical trial NCT04630847?
This trial is sponsored by ProgenaBiome, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.